- ►diabetesjournals.org K Mai, J Andres, K Biedasek, J Weicht, T … - Diabetes, 2009 - Am Diabetes Assoc OBJECTIVE Fibroblast growth factor (FGF)-21 improves insulin sensitivity and
lipid metabolism in obese or diabetic animal models, while human studies
revealed increased FGF-21 levels in obesity and type 2 diabetes. Given that ... Cited by 1 - Related articles - All 3 versions
R Micanovic, DW Raches, JD Dunbar, DA … - J Cell Physiol, 2009 - interscience.wiley.com Fibroblast growth factor 21 is a member of endocrine FGFs subfamily, along with
FGF19 and FGF23. It is emerging as a novel regulator with beneficial effects on
a variety of metabolic parameters, including glucose and lipid control. ... Cited by 5 - Related articles - All 2 versions
- ►pubget.com [PDF] J Yie, R Hecht, J Patel, J Stevens, W Wang, N … - FEBS letters, 2009 - Elsevier Fibroblast growth factor-21 (FGF21) signaling requires the presence of
β-Klotho, a co-receptor with a very short cytoplasmic domain. Here we show that
FGF21 binds directly to β-Klotho through its C-terminus. Serial C-terminal ... Cited by 5 - Related articles - All 3 versions
- ►endojournals.org I Dostalova, P Kavalkova, D Haluzikova, Z … - Journal of Clinical Endocrinology & Metabolism, 2008 - Endocrine Soc Context: Fibroblast growth factor 19 (FGF19) and FGF21 are novel metabolic
regulators that improve insulin sensitivity and decrease adiposity in mice.
However, little is known about the nutritional regulation of these factors ... Cited by 9 - Related articles - All 3 versions
- ►aspetjournals.org ES Muise, B Azzolina, DW Kuo, M El- … - Molecular Pharmacology, 2008 - ASPET Adipose tissue is a metabolically responsive endocrine organ that secretes a
myriad of adipokines. Antidiabetic drugs such as peroxisome
proliferator-activated receptor (PPAR) agonists target adipose tissue gene ... Cited by 10 - Related articles - All 3 versions
H Li, Y Bao, A Xu, X Pan, J Lu, H Wu, H Lu, K … - Journal of Clinical Endocrinology & Metabolism, 2009 - Endocrine Soc Design: Serum FGF21 levels were determined by ELISA in 134 normal glucose
tolerance (NGT), 101 isolated-impaired fasting glucose, and 118
isolated-impaired glucose tolerance (I-IGT) Chinese subjects, and their ... Cited by 3 - Related articles - All 3 versions
EK Naderali, C Wong, M Hussain - Diabetes & Metabolic Syndrome: Clinical Research & …, 2009 - Elsevier Fibroblast growth factor 21 (FGF-21) is a novel peptide that primarily produced
by liver which is thought to exert beneficial effects on lipid and carbohydrate
metabolism. It is becoming an emerging candidate to mange obesity and ... Related articles
- ►nih.gov T Inagaki, VY Lin, R Goetz, M Mohammadi, DJ … - Cell metabolism, 2008 - Elsevier Starvation blocks the actions of growth hormone (GH) and inhibits growth through
mechanisms that are not well understood. In this report, we demonstrate that
fibroblast growth factor 21 (FGF21), a hormone induced by fasting, causes ... Cited by 10 - Related articles - All 6 versions
- ►endojournals.org [PDF] T Coskun, HA Bina, MA Schneider, JD Dunbar … - Endocrinology, 2008 - Endocrine Soc Page 1. 1 FGF21 Corrects Obesity in Mice Tamer Coskun, Holly A. Bina, Michael
A. Schneider, James D. Dunbar, Charlie C. Hu, Yanyun ... Cited by 12 - Related articles
WW Chen, L Li, GY Yang, K Li, XY Qi, W Zhu, … - Experimental and clinical endocrinology & diabetes: …, 2008 - ncbi.nlm.nih.gov 1: Exp Clin Endocrinol Diabetes. 2008 Jan;116(1):65-8. Epub 2007 Oct 9.
Circulating FGF-21 levels in normal subjects and in newly ... Cited by 14 - Related articles - BL Direct - All 3 versions
